The systolic BP was recorded as 120 mmHg. Anaesthesia was induced with thiopentone 350 mg, fentanyl 200 I-Ig and atracurium 50 mg intravenously. After 90 seconds the trachea was intubated, and it was immediately noticed that the lungs were difficult to inflate. Auscultation of the chest confirmed severe bronchospasm. Intense flushing developed over the upper trunk almost immediately. The systolic BP was measured at 90 mmHg and 15 seconds later at 70 mmHg.
A diagnosis of anaphylaxis was made and adrenaline 7 ml 1:10,000 (0.7 mg) given as an intravenous bolus. The systolic BP by this time was 40 mmHg. The lungs were ventilated with 100% oxygen and intravenous fluids given rapidly. The BP rose rapidly and a second intravenous line was inserted. The bronchospasm cleared with the initial dose of adrenaline but the blood pressure remained unstable.
Over the next 45 minutes a total of 35 ml of 1: 10 ,000 adrenaline (3.5 mg) was given, along with 2.5 litres of Hartmann's solution, 2 litres of stable plasma protein solution (SPPS), solumedrol 1.0 g, sodium bicarbonate 40 mEq, lignocaine 40 mg and promethazine 25 mg. Following the insertion of a left radial arterial line and urinary catheter, the patient was transferred to the Intensive Care Unit (ICU). Blood gases immediately prior to the transfer were pH 7.18, PaC02 41 mmHg, Pa02 253 mmHg, base excess -12.8. A further 100 mEq sodium bicarbonate was given in the ICU and blood gases following this were pH 7.22, PaC02 37 mmHg, Pa02 527 mmHg, base excess -12.1.
Soon afterwards, severe pulmonary oedema developed and artificial ventilation was continued with the addition of PEEP 15 cm H20. The central venous pressure was measured at 25 cm H20, systolic BP 70 mmHg and urine output at 5 ml in 30 minutes. A dopamine infusion (2 J1g/kg/min) was commenced, the BP rose to 90 mmHg and the urine output improved dramatically over the next hour. The pulmonary oedema slowly cleared over the next 12 hours as demonstrated clinically and by chest X-ray. Artificial ventilation was continued for 24 hours and after a further 12 hours the patient was transferred back to the general ward. She was discharged seven days later, having made a complete recovery.
Six weeks later she returned for skin testing according to Fisher's protocol. 6 Intradermal injections of 0.1 ml were made into the flexor aspect of the left forearm using the following dilutions: fentanyl 1 in 1000, thiopentone 1 in 100, atracurium 1 in 1000, atracurium 1 in 10,000, and saline 0.9070. A positive weal was obtained with both dilutions of atracurium.
One week later she returned for further skin testing with the following drugs: suxamethonium 1 in 1000, pancuronium 1 in 1000, alcuronium 1 in 1000, d-tubocurarine 1 in 10,000 and atracurium 1 in 1000. A positive weal was again only obtained with atracurium.
Skin testing to atracurium 1 in 1000 and 0.9070 saline was also performed on three volunteer controls. Three patients who had had atracurium uneventfully between 30 days and 80 days previously were also tested. These tests were uniformly negative. 
DISCUSSION
This patient suffered a severe anaphylactic reaction to atracurium. The mechanism of this reaction is not easy to explain as there was no possibility of prior exposure. Serial complement levels were not performed. Crosssensitisation with some other unknown agent, perhaps cosmetics as has been suggested in the case of anaphylaxis to other neuromuscular blocking drugs, would have to be considered.
The successful management of a severe anaphylactic reaction depends upon early recognition and prompt aggressive treatment. The value of establishing intravenous infusions and ECG monitoring prior to induction of anaesthesia is stressed. The role of adrenaline as the drug of choice in the treatment of such cases is also underlined.
